| Net income (loss) | |
| Depreciation and amortization | |
| Reversal of legal settlements, net | |
| Provision for doubtful accounts | 1.35M |
| Non-cash compensation | 3.49M |
| Loss in equity interests, net | 13K |
| Non-cash restructuring write-offs, accelerated amortization and loss on disposal of assets | |
| Deferred income taxes | -41.39M |
| (Gains) losses on auction rate securities | |
| Accounts receivable | 48.07M |
| Prepaid and other | 9.68M |
| Deferred revenue | -54.69M |
| Accounts payable, accrued liabilities and other | -33.05M |
| Total adjustments | 292.32M |
| Net cash provided by operating activities | |
| Capital expenditures | -30.46M |
| Payments for acquisitions and intangible assets, net of cash acquired | -12.51M |
| Purchase of marketable securities | |
| Sales and maturities of marketable securities and other | |
| Cash funded to equity investee | |
| Dividends received from unconsolidated investee | |
| Net cash (used for) provided by investing activities | |
| Proceeds from borrowings on credit facilities | 0 |
| Payments on borrowings on term loan and revolving credit facilities | 0 |
| Proceeds from borrowings on term loan | |
| Repurchase of common stock | -3.04M |
| Tax withholdings related to net share settlements of restricted stock awards and units | -950K |
| Proceeds from the exercise of employee stock options | |
| Excess tax benefits from equity compensation plans | 0 |
| Net cash provided by (used for) financing activities | |
| Effects of exchange rates on cash | 622K |
| Net increase (decrease) in cash and cash equivalents | -76.03M |
| Cash and cash equivalents, beginning of period | 167.92M |
| Cash and cash equivalents, end of period | 91.89M |